Thoracic Imaging Department, The University of Texas, M.D, Anderson Cancer Center, Houston, TX.
Department of Medical Imaging, The University of Arizona- Banner Medical Center, Tucson, AZ.
Semin Ultrasound CT MR. 2021 Dec;42(6):535-541. doi: 10.1053/j.sult.2021.04.016. Epub 2021 May 8.
The management of patients with esophageal carcinoma (EC) requires accurate clinical staging and post-therapeutic evaluation. Currently, esophagogastroduodenoscopy/endoscopic ultrasound (EGD/EUS), endoscopic ultrasound-fine needle aspiration (EUS-FNA), computed tomography (CT), 18F- fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) and magnetic resonance (MR) imaging are used for the initial clinical staging, evaluation of therapeutic response and follow-up in patients with EC. However, there are limitations and pitfalls that are commonly encountered when imaging these patients that can limit accurate assessment. Knowledge of the limitations and pitfalls associated with the use of these different imaging modalities is essential in avoiding misinterpretation and guaranteeing the appropriate management for patient with EC.
食管癌（EC）患者的管理需要准确的临床分期和治疗后评估。目前，食管胃十二指肠镜/内镜超声（EGD/EUS）、内镜超声引导下细针抽吸（EUS-FNA）、计算机断层扫描（CT）、18F-氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）和磁共振（MR）成像用于 EC 患者的初始临床分期、治疗反应评估和随访。然而，在对这些患者进行影像学检查时，通常会遇到一些限制和陷阱，这些限制和陷阱会限制准确评估。了解与使用这些不同成像方式相关的局限性和陷阱对于避免误诊和保证 EC 患者的适当治疗至关重要。
